Alberto Migliore

Summary

Affiliation: Hospital Universitario
Country: Spain

Publications

  1. pmc Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip
    Alberto Migliore
    Operative Unit of Rheumatology, San Pietro Fatebenefratelli Hospital, Via Cassia 600, 00189 Rome, Italy
    Arthritis Res Ther 11:R183. 2009
  2. ncbi A new technical contribution for ultrasound-guided injections of sacro-iliac joints
    A Migliore
    UOS of Rheumatology, S Pietro Fatebenefratelli Hospital, Rome, Italy
    Eur Rev Med Pharmacol Sci 14:465-9. 2010
  3. doi Intra-articular injection of hyaluronic acid (MW 1,500-2,000 kDa; HyalOne) in symptomatic osteoarthritis of the hip: a prospective cohort study
    Alberto Migliore
    Operative Unit of Rheumatology, S Pietro Fatebenefratelli Hospital, Via Cassia 600, 00189 Rome, Italy
    Arch Orthop Trauma Surg 131:1677-85. 2011
  4. ncbi Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis
    A Migliore
    S Pietro Fatebenefratelli Hospital, Rome, Italy
    Eur Rev Med Pharmacol Sci 17:658-67. 2013
  5. doi Total hip replacement rate in a cohort of patients affected by symptomatic hip osteoarthritis following intra-articular sodium hyaluronate (MW 1,500-2,000 kDa) ORTOBRIX study
    Alberto Migliore
    Operative Unit of Rheumatology, San Pietro Fatebenefratelli Hospital Research Center, Via Cassia 600, 00189 Rome, Italy
    Clin Rheumatol 31:1187-96. 2012
  6. doi The impact of treatment with hylan G-F 20 on progression to total hip arthroplasty in patients with symptomatic hip OA: a retrospective study
    A Migliore
    Department of Rheumatology, San Pietro Fatebenefratelli Hospital, Rome, Italy
    Curr Med Res Opin 28:755-60. 2012
  7. doi Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator
    Alberto Migliore
    UO of Rheumatology, S Pietro Fatebenefratelli Hospital, Via Cassia 600, 00189 Rome, Italy
    Clin Rheumatol 31:133-7. 2012
  8. ncbi The safety of anti-TNF agents in the elderly
    A Migliore
    UOS of Rheumatology, S Pietro FBF Hospital, Research Center S Pietro, Rome, Italy
    Int J Immunopathol Pharmacol 22:415-26. 2009
  9. ncbi Relevance of 99mTc-HYNIC-tir-octreotide scintigraphy in a patient affected by sarcoidosis with lung and joints involvement and secondary Sjogren's syndrome treated with infliximab: case report
    A Migliore
    UOS of Rheumatology, Fatebenefratelli, S Pietro Hospital, Rome, Italy
    Eur Rev Med Pharmacol Sci 12:127-30. 2008
  10. ncbi Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice
    Alberto Migliore
    U O S of Rheumatology, Ospedale San Pietro Fatebenefratelli, Rome, Italy
    Curr Med Res Opin 24:1309-16. 2008

Collaborators

  • Prisco Piscitelli
  • Cesare Hassan
  • Bruno Frediani
  • M Chianelli
  • B Marasini
  • A Signore
  • M Ranieri
  • Luigi Gatta
  • A Capuano
  • Vincenzo Bruzzese
  • Roberto Lorenzetti
  • Bruno Lagana
  • Luis Severino Martin Martin
  • Angelo Zullo
  • Lorenzo Ridola
  • Emanuele Bizzi
  • Umberto Massafra
  • Sandro Tormenta
  • Andrea Picchianti-Diamanti
  • I Pavese
  • R Manna
  • B Lagana
  • Cinzia Marrese
  • Andrea Piacchianti Diamanti
  • Vincenzo De Francesco
  • Palma Scolieri
  • Alessandro Armuzzi
  • Andrea Picchianti Diamanti
  • Davide Orlandi
  • Francesca Iannessi
  • Luca Maria Sconfienza
  • F Todi
  • E Brunetti
  • P Piselli
  • R Borghesi
  • G Mancino
  • Claudia Ferlito
  • A Alimonti
  • Raffaele D'Amelio
  • F Satta
  • M Di Palma
  • Valentina Germano
  • P Piergrossi
  • C Fonnesu
  • G Gasbarrini
  • A Soriano
  • A Picchianti Diamanti
  • U Massafra
  • C Cerquaglia
  • C Ferlito
  • R D'Amelio
  • M Giovinale
  • S Salemi
  • E Verrecchia
  • G De Socio
  • M Granata
  • A Cremona
  • G Argento
  • V Germano
  • V David
  • V Curigliano

Detail Information

Publications33

  1. pmc Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip
    Alberto Migliore
    Operative Unit of Rheumatology, San Pietro Fatebenefratelli Hospital, Via Cassia 600, 00189 Rome, Italy
    Arthritis Res Ther 11:R183. 2009
    ..Comparison of intra-articular bacterial-derived hyaluronic acid (Hyalubrix) (HA) with local analgesia (mepivacaine) for osteoarthritis (OA) of the hip...
  2. ncbi A new technical contribution for ultrasound-guided injections of sacro-iliac joints
    A Migliore
    UOS of Rheumatology, S Pietro Fatebenefratelli Hospital, Rome, Italy
    Eur Rev Med Pharmacol Sci 14:465-9. 2010
    ..However, in selected patients, local therapies may be considered. Some recent studies demonstrated the feasibility of ultrasound (US)-guided injection of SIJ, but still a complete explanation and definition of the technique is needed...
  3. doi Intra-articular injection of hyaluronic acid (MW 1,500-2,000 kDa; HyalOne) in symptomatic osteoarthritis of the hip: a prospective cohort study
    Alberto Migliore
    Operative Unit of Rheumatology, S Pietro Fatebenefratelli Hospital, Via Cassia 600, 00189 Rome, Italy
    Arch Orthop Trauma Surg 131:1677-85. 2011
    ..This study investigated the long-term efficacy and tolerability of ultrasound-guided intra-articular sodium hyaluronate (MW 1,500-2,000 kDa; Hyalone) injections in daily clinical practice...
  4. ncbi Ranking antireabsorptive agents to prevent vertebral fractures in postmenopausal osteoporosis by mixed treatment comparison meta-analysis
    A Migliore
    S Pietro Fatebenefratelli Hospital, Rome, Italy
    Eur Rev Med Pharmacol Sci 17:658-67. 2013
    ..Mixed treatment comparison, an extension of traditional meta-analysis, is able to compare simultaneously several drugs across a range producing a synthetic evidence of efficacy and a range of probability as to the best treatment...
  5. doi Total hip replacement rate in a cohort of patients affected by symptomatic hip osteoarthritis following intra-articular sodium hyaluronate (MW 1,500-2,000 kDa) ORTOBRIX study
    Alberto Migliore
    Operative Unit of Rheumatology, San Pietro Fatebenefratelli Hospital Research Center, Via Cassia 600, 00189 Rome, Italy
    Clin Rheumatol 31:1187-96. 2012
    ..Although further studies are necessary to confirm these data and to identify outcome predictors, hip viscosupplementation should be considered as conservative treatment to perform before proposing patients for THR...
  6. doi The impact of treatment with hylan G-F 20 on progression to total hip arthroplasty in patients with symptomatic hip OA: a retrospective study
    A Migliore
    Department of Rheumatology, San Pietro Fatebenefratelli Hospital, Rome, Italy
    Curr Med Res Opin 28:755-60. 2012
    ..There is scarce data available on intra-articular hyaluronan's ability to modify the progression of osteoarthritis (OA)...
  7. doi Indirect comparison of etanercept, infliximab, and adalimumab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator
    Alberto Migliore
    UO of Rheumatology, S Pietro Fatebenefratelli Hospital, Via Cassia 600, 00189 Rome, Italy
    Clin Rheumatol 31:133-7. 2012
    ..This analysis may be relevant for clinical decision-making, hence improving the management of PsA patients...
  8. ncbi The safety of anti-TNF agents in the elderly
    A Migliore
    UOS of Rheumatology, S Pietro FBF Hospital, Research Center S Pietro, Rome, Italy
    Int J Immunopathol Pharmacol 22:415-26. 2009
    ..Applying the recommended screening before using biological treatment helps to reduce adverse events related to the therapy, and the application of the same screening in elderly patients seems to lead to comparable results...
  9. ncbi Relevance of 99mTc-HYNIC-tir-octreotide scintigraphy in a patient affected by sarcoidosis with lung and joints involvement and secondary Sjogren's syndrome treated with infliximab: case report
    A Migliore
    UOS of Rheumatology, Fatebenefratelli, S Pietro Hospital, Rome, Italy
    Eur Rev Med Pharmacol Sci 12:127-30. 2008
    ..99mTc-HYNIC-TOC scintigraphy was useful in diagnosis, choice of treatment and follow-up...
  10. ncbi Intra-articular administration of hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice
    Alberto Migliore
    U O S of Rheumatology, Ospedale San Pietro Fatebenefratelli, Rome, Italy
    Curr Med Res Opin 24:1309-16. 2008
    ..This prospective, observational, open study aimed to assess the efficacy and safety of hylan G-F 20 in a large cohort of patients with symptomatic hip osteoarthritis (OA), and identify predictors of clinical response...
  11. ncbi Combined use of teriparatide and TNFalpha blockade: safety
    Alberto Migliore
    Department of Rheumatology, Ospedale S Pietro, 00189 Rome, Italy
    Aging Clin Exp Res 19:18-20. 2007
    ..During the 9-month follow-up period, we did not observe any new symptomatic fractures or infections in treated patients, but we found a reduction in parameters indicating inflammation; no differences were found in biochemical parameters...
  12. ncbi Multiple chemical sensitivity syndrome in Sjögren's syndrome patients: casual association or related diseases?
    Alberto Migliore
    Department of Rheumatology at San Pietro Fatebenefratelli Hospital and Centro Ricerche, Association Fatebenefratelli for Research, Rome, Italy
    Arch Environ Occup Health 61:285-7. 2006
    ..Three women who were diagnosed with SS showed MCS symptoms and also were diagnosed with MCS. Further studies are needed to understand physiopathogenic mechanisms that eventually may be revealed as common to the 2 syndromes...
  13. ncbi The symptomatic effects of intra-articular administration of hylan G-F 20 on osteoarthritis of the hip: clinical data of 6 months follow-up
    Alberto Migliore
    Research Center S Pietro Hospital, Fatebenefratelli AFaR, Via Cassia 600, 00189 Rome, Italy
    Clin Rheumatol 25:389-93. 2006
    ..The present observation suggests the potentiality for the safety and efficacy of hylan G-F 20 injected under US guidance in patients with symptomatic hip OA. Further controlled studies are needed...
  14. doi Health-related quality of life and disability in patients with rheumatoid, early rheumatoid and early psoriatic arthritis treated with etanercept
    Andrea Picchianti-Diamanti
    Division of Clinical Immunology and Rheumatology, S Andrea University Hospital, Sapienza University of Rome, II School of Medicine, Via di Grottarossa 1039, 00189 Rome, Italy
    Qual Life Res 19:821-6. 2010
    ..To assess health-related quality of life (HR-QoL) in patients with Rheumatoid arthritis (RA), early RA and early psoriatic arthritis (PsA), and to evaluate the efficacy of etanercept in reducing disability...
  15. doi Viscosupplementation in the management of ankle osteoarthritis: a review
    Alberto Migliore
    Rheumatology, S Pietro FBF Hospital, Via Cassia 600, 00189 Rome, Italy
    Arch Orthop Trauma Surg 131:139-47. 2011
    ..The objective of this review is to assess the efficacy of viscosupplementation treatment of ankle osteoarthritis in the current literature...
  16. ncbi Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis
    Alberto Migliore
    Department of Internal Medicine, S Pietro Fatebenefratelli Hospital, via Cassia 600 Centro ricerche S Pietro AFaR, 00195, Rome, Italy
    Clin Rheumatol 24:285-9. 2005
    ....
  17. doi Vitamin D deficiency in patients with either rheumatic diseases or inflammatory bowel diseases on biologic therapy
    Vincenzo Bruzzese
    Medicina Interna, Reumatologia e Gastroenterologia, Ospedale Nuovo Regina Margherita, Via E Morosini, 30, 00153, Rome, Italy
    Intern Emerg Med 11:803-7. 2016
    ..9 %; p = 0.03), while PTH values did not differ significantly. This study finds that the prevalence of vitamin D deficiency/insufficiency was very high in patients with either rheumatic diseases or IBD receiving a biologic therapy. ..
  18. doi Prevalence study of iliopsoas bursitis in a cohort of 860 patients affected by symptomatic hip osteoarthritis
    Sandro Tormenta
    Department of Diagnostic Imaging, S Pietro Fatebenefratelli Hospital, Rome, Italy
    Ultrasound Med Biol 38:1352-6. 2012
    ..VAS index and Lequesne index were not significantly different between patients with or without IB (p ≥ 0.468). Ultrasound can detect associate findings in grade II-IV hip osteoarthritis patients with high reproducibility...
  19. doi The Challenge of Treating Early-Stage Rheumatoid Arthritis: The Contribution of Mixed Treatment Comparison to Choosing Appropriate Biologic Agents
    Alberto Migliore
    Rheumatology Department, San Pietro Fatebenefratelli Hospital, Via Cassia 600, 00189, Rome, Italy
    BioDrugs 30:105-15. 2016
    ..Only a few indirect comparisons of the efficacy of different biologic agents in established RA have been performed and, to date, no studies reporting direct comparisons have been performed in ERA...
  20. pmc Intra-articular use of hyaluronic acid in the treatment of osteoarthritis
    Alberto Migliore
    UOS of Rheumatology, S Pietro Fatebenefratelli Hospital, Rome, Italy
    Clin Interv Aging 3:365-9. 2008
    ..Large scale double blind controlled studies must be carried out to confirm these promising data and produce meaningful guidelines...
  21. pmc A double blind randomized active-controlled clinical trial on the intra-articular use of Md-Knee versus sodium hyaluronate in patients with knee osteoarthritis ("Joint")
    Luis Severino Martin Martin
    Department of Internal Medicine, Regina Apostolorum Hospital, Via S Francesco 50, Albano Laziale, Rome, Italy
    BMC Musculoskelet Disord 17:94. 2016
    ..To evaluate the clinical outcomes of a group of patients affected by knee osteoarthritis (OA) treated with MD-Knee (Guna S.p.a., Milan, Italy) versus a group of patients treated with sodium hyaluronate...
  22. ncbi Imaging progression despite clinical remission in early rheumatoid arthritis patients after etanercept interruption
    B Lagana
    Department of Medical Sciences, Sapienza University of Rome, 2nd School of Medicine, S Andrea University Hospital, Rome, Italy
    Int J Immunopathol Pharmacol 22:447-54. 2009
    ..However, it indicates that joint damage may progress, despite a sustained clinical remission, after Etn suspension...
  23. doi Indirect comparison between subcutaneous biologic agents in ankylosing spondylitis
    Alberto Migliore
    Department of Rheumatology, Rheumatology Unit, S Pietro Fatebenefratelli Hospital, Via Cassia 600, 00189, Rome, Italy
    Clin Drug Investig 35:23-9. 2015
    ....
  24. doi Biologic agents for rheumatoid arthritis: can we hypothesize new strategies of treatment?
    Alberto Migliore
    Unit of Rheumatology, S Pietro FBF Hospital, Research Center S Pietro, Via Cassia 600, 00189 Rome, Italy Electronic address
    Med Hypotheses 82:117-21. 2014
    ..According to these observations, adequate clinical trials should be designed to search for appropriate drugs associations and dosages. ..
  25. ncbi TNF-alpha blockade induce clinical remission in patients affected by polymyalgia rheumatica associated to diabetes mellitus and/or osteoporosis: a seven cases report
    A Migliore
    Department of Internal Medicine, S Pietro AFaR Hospital, Rome, Italy
    Eur Rev Med Pharmacol Sci 9:373-8. 2005
    ....
  26. ncbi Can Cyclosporine-A associated to methotrexate maintain remission induced by anti-TNF agents in rheumatoid arthritis patients? (Cynar pilot study)
    A Migliore
    Operative Unit of Rheumatology, S Pietro FBF Hospital, Rome, Italy
    Int J Immunopathol Pharmacol 23:783-90. 2010
    ..Further studies on larger populations are necessary in order to confirm such results and identify predictor factors for different responses...
  27. doi Is it the time to rethink clinical decision-making strategies? From a single clinical outcome evaluation to a Clinical Multi-criteria Decision Assessment (CMDA)
    Alberto Migliore
    UO of Rheumatology, Ospedale S Pietro FBF, Rome, Italy Electronic address
    Med Hypotheses 85:433-40. 2015
    ..The use of CMDA model will yield a clear and complete indication of the best pharmaceutical treatment to use for patients, helping physicians to choose drugs with a complete set of information, imputed in the model. ..
  28. doi Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials
    Roberto Lorenzetti
    Internal Medicine, Rheumatology and Gastroenterology, Nuovo Regina Margherita Hospital, Rome, Italy
    Ann Med 46:547-54. 2014
    ..Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies...
  29. ncbi Efficacy and safety of viscosupplementation by ultrasound-guided intra-articular injection in osteoarthritis of the hip
    A Migliore
    Department of Internal Medicine, S Pietro Fatebenefratelli Hospital, Rome, Italy
    Osteoarthritis Cartilage 11:305-6. 2003
  30. ncbi [Safety profile of 185 ultrasound-guided intra-articular injections for treatment of rheumatic diseases of the hip]
    A Migliore
    Dipartimento Medicina Interna, Ospedale S Pietro Fatebenefratelli, Rome, Italy
    Reumatismo 56:104-9. 2004
    ..The purpose of this study was to examine the safety of this technique in an extended series of patients...
  31. ncbi Cyclosporine A: good response for patients affected by autoimmune disorders and HCV infection?
    R Manna
    Department of Internal Medicine, Catholic University of the Sacred Heart, Rome, Italy
    Eur Rev Med Pharmacol Sci 13:63-9. 2009
    ..Cyclosporine A (CsA), in standard therapeutic doses, has been proven able to inhibit HCV cyclophilin in vitro. Therefore CsA could improve the therapy of HCV patients with ADs...
  32. doi High serum levels of TNF-α and IL-6 predict the clinical outcome of treatment with human recombinant erythropoietin in anaemic cancer patients
    I Pavese
    Department of Oncology, San Pietro Fatebenefratelli Hospital, Rome, Italy
    Ann Oncol 21:1523-8. 2010
    ....
  33. ncbi [18-month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis]
    Alberto Migliore
    U O S di Reumatologia, S Pietro Fatebenefratelli Ospedale, 00189 Roma
    Reumatismo 58:39-49. 2006
    ..To evaluate the efficacy and the tolerability of viscosupplementation (VS) with hyaluronic acid (Hylan GF 20) in a cohort of 36 patients affected by hip osteoarthritis through a 18 months follow-up...